-
EP2156191
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP2156191
| EP2156191 - METHODS AND KITS FOR PREDICTING TREATMENT RESPONSE IN TYPE II DIABETES MELLITUS PATIENTS [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 11.05.2012 Database last updated on 28.06.2024 | Most recent event Tooltip | 11.05.2012 | Application deemed to be withdrawn | published on 13.06.2012 [2012/24] | Applicant(s) | For all designated states GlaxoSmithKline LLC One Franklin Plaza 200 North 16th Street Philadelphia, PA 19102 / US | For all designated states BG Medicine, Inc. 610 N. Lincoln Street Waltham, MA 02451 / US | [N/P] |
| Former [2010/09] | For all designated states GlaxoSmithKline LLC One Franklin Plaza 200 North 16th Street Philadelphia, PA 19102 / US | ||
| For all designated states BG Medicine, Inc. 601 n. Lincoln Street Waltham, MA 02451 / US | |||
| Former [2010/08] | For all designated states Smithkline Beecham Corporation One Franklin Plaza PO Box 7929 Philadelphia, PA 19101 / US | ||
| For all designated states BG Medicine, Inc. 601 n. Lincoln Street Waltham, MA 02451 / US | Inventor(s) | 01 /
QIU, Yang 121 Brookbank Hill Place Cary, NC 27519 / US | 02 /
RAJAGOPALAN, Dilip 30 Ridgeview Road Newtown Square, PA 19073 / US | 03 /
ZHU, Lei 4615 Regency Drive Durham, NC 27713 / US | 04 /
CONNOR, Susan, C. Park Road Ware, Hertfordshire SG12 ODP / GB | 05 /
HU, Guanghui 313 Quail Drive North Phoenixville, PA 19460 / US | 06 /
MACLEAN, David 9 Stimpson Street Middletown, RI 02842 / US | 07 /
DAMIAN, Doris 40 Hatfield Road West Newton, MA 02451 / US | 08 /
HANDZEL, Amir 1463 Church Street, 2nd Floor Rahway, NJ 07065 / US | 09 /
BALASUBRAMANIAN, Rajalakshmi 21 Sylvan Way Wayland, MA 01778 / US | [2010/26] |
| Former [2010/08] | 01 /
QIU, Yang 121 Brookbank Hill Place Cary, NC 27519 / US | ||
| 02 /
RAJAGOPALAN, Dilip 30 Ridgeview Road Newtown Square, PA 19073 / US | |||
| 03 /
ZHU, Lei 4615 Regency Drive Durham, NC 27713 / US | |||
| 04 /
CONNOR, Susan, C. Park Road Ware, Hertfordshire SG12 ODP / GB | |||
| 05 /
HU, Guanghui 313 Quail Drive North Phoenixville, PA 19460 / US | |||
| 06 /
MACLEAN, David 9 Stimpson Street Middletown, RI 02842 / US | |||
| 07 /
DAMIAN, Doris 40 Hatfield Road West Newton, MA 02451 / US | |||
| 08 /
HANDZEL, Amir 42 Hillcrest Circle Watertown, MA 02472 / US | |||
| 09 /
BALASUBRAMANIAN, Rajalakshmi 21 Sylvan Way Wayland, MA 01778 / US | Representative(s) | Dörries, Hans Ulrich, et al df-mp Dörries Frank-Molnia & Pohlman Patentanwälte Rechtsanwälte PartG mbB Theatinerstrasse 16 80333 München / DE | [N/P] |
| Former [2010/08] | Dörries, Hans Ulrich, et al df-mp Fünf Höfe Theatinerstrasse 16 80333 München / DE | Application number, filing date | 08768360.3 | 11.06.2008 | [2010/08] | WO2008US07304 | Priority number, date | US20070934661P | 15.06.2007 Original published format: US 934661 P | [2010/08] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO2008156617 | Date: | 24.12.2008 | Language: | EN | [2008/52] | Type: | A2 Application without search report | No.: | EP2156191 | Date: | 24.02.2010 | Language: | EN | The application published by WIPO in one of the EPO official languages on 24.12.2008 takes the place of the publication of the European patent application. | [2010/08] | Search report(s) | International search report - published on: | EP | 26.02.2009 | Classification | IPC: | G01N33/68, G06F19/00 | [2010/08] | CPC: |
G01N33/6893 (EP,US);
G16B40/00 (EP,US);
G16H20/60 (EP,US);
G01N2333/54 (EP,US);
G01N2800/042 (EP,US);
Y10T436/143333 (EP,US);
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR [2010/08] | Extension states | AL | Not yet paid | BA | Not yet paid | MK | Not yet paid | RS | Not yet paid | Title | German: | VERFAHREN UND KITS ZUR VORHERSAGE DER REAKTION AUF EINE BEHANDLUNG BEI PATIENTEN MIT DIABETES MELLITUS TYP 2 | [2010/08] | English: | METHODS AND KITS FOR PREDICTING TREATMENT RESPONSE IN TYPE II DIABETES MELLITUS PATIENTS | [2010/08] | French: | PROCÉDÉS ET KITS POUR PRÉDIRE UNE RÉPONSE DE TRAITEMENT DANS DES PATIENTS PRÉSENTANT UN DIABÈTE SUCRÉ DE TYPE II | [2010/08] | Entry into regional phase | 08.12.2009 | National basic fee paid | 08.12.2009 | Designation fee(s) paid | 08.12.2009 | Examination fee paid | Examination procedure | 08.12.2009 | Examination requested [2010/08] | 01.03.2010 | Amendment by applicant (claims and/or description) | 03.09.2010 | Despatch of a communication from the examining division (Time limit: M06) | 03.03.2011 | Reply to a communication from the examining division | 12.08.2011 | Despatch of a communication from the examining division (Time limit: M04) | 23.12.2011 | Application deemed to be withdrawn, date of legal effect [2012/24] | 30.01.2012 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2012/24] | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 03.09.2010 | Fees paid | Renewal fee | 25.06.2010 | Renewal fee patent year 03 | Penalty fee | Additional fee for renewal fee | 30.06.2011 | 04 M06 Not yet paid |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [A]WO2004100781 (CLINIGENE INTERNAT PRIVATE LTD [IN], et al) [A] 1-13,22-34,50,52-62* claims 1,2,5,13,55 *; | [A]WO2005046734 (MERCK & CO INC [US], et al) [A] 1-13,22-34,50,52-62 * relevant for non unity * * page 7, line 9 - line 20 * * page 8, line 17 - line 27 * * claims 22,25,29-33 *; | [A]WO2007038670 (PERLEGEN SCIENCES INC [US], et al) [A] 1-13,22-34,50,52-60 * relevant for non unity * * claims 1,12-21,34,35,44-47 *; | [A] - SESTI GIORGIO ET AL, "The Arg972 variant in insulin receptor substrate-1 is associated with an increased risk of secondary failure to sulfonylurea in patients with type 2 diabetes.", DIABETES CARE JUN 2004, (200406), vol. 27, no. 6, ISSN 0149-5992, pages 1394 - 1398, XP002497290 [A] 1-13,22-34,50,52-62 * abstract * * table 1 * * page 1397, column 2, paragraph 2 * DOI: http://dx.doi.org/10.2337/diacare.27.6.1394 | [A] - ARAKI TAKAHIRO ET AL, "Insulin resistance index as a predictor for pioglitazone treatment in type 2 diabetes.", OSAKA CITY MEDICAL JOURNAL JUN 2005, (200506), vol. 51, no. 1, ISSN 0030-6096, pages 19 - 25, XP008096645 [A] 1-13,22-34,50,52-62 * abstract * * page 21, paragraph 1 - paragraph 3 * * page 22, paragraph 2 * * figure 1 * | [A] - LEITER EDWARD H ET AL, "Differential endocrine responses to rosiglitazone therapy in new mouse models of type 2 diabetes.", ENDOCRINOLOGY FEB 2006, (200602), vol. 147, no. 2, ISSN 0013-7227, pages 919 - 926, XP002497336 [A] 1-13,22-34,50,52-62 * abstract * DOI: http://dx.doi.org/10.1210/en.2005-0839 | [A] - BRUUN J M ET AL, "Interleukin-8 production in human adipose tissue. Inhibitory effects of anti-diabetic compounds, the thiazolidinedione Ciglitazone and the biguanide Metformin", HORMONE AND METABOLIC RESEARCH, (200011), vol. 32, no. 11-12, ISSN 0018-5043, pages 537 - 541, XP008096646 [A] 1-13,22-34,50,52-62 * abstract * * figures 1,2 * DOI: http://dx.doi.org/10.1055/s-2007-978682 | [A] - DESMET CHRISTOPHE ET AL, "Pro-inflammatory properties for thiazolidinediones.", BIOCHEMICAL PHARMACOLOGY 15 JAN 2005, (20050115), vol. 69, no. 2, ISSN 0006-2952, pages 255 - 265, XP002497291 [A] 1-13,22-34,50,52-62 * abstract * DOI: http://dx.doi.org/10.1016/j.bcp.2004.09.017 |